Biopharmaceutical Analysis

Capturing the Nuances of Immune Cells Using Glycobiology

Glycosylation analysis can provide a deep and nuanced understanding of immune cell phenotype and function.

Examining Next-Gen Technology for Adventitious Agent Testing

Adventitious agent testing is transitioning toward testing methods that use next-generation sequencing.

Image Analysis Algorithm for Therapeutic mAb Aggregate Analysis

Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.

AbbVie Collaborates with BigHat Biosciences on Next-Gen Therapeutic Antibodies

December 08, 2023

This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.

MilliporeSigma Launches AI Solution for Integrating Drug Discovery and Molecule Synthesis

December 08, 2023

MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.

Stability Studies: An Essential Step for Quality Management in Drug Development

December 01, 2023

Sufficient stability studies show a drug product meets regulatory requirements, therefore ensuring the drug reaches the patients who rely on it.

TAU Systems to Establish TAU Labs, a New Laser Plasma Accelerator Application Center

November 29, 2023

TAU Systems plans to establish TAU Labs, a new next-generation, laser-driven plasma accelerator laboratory, in Carlsbad, Calif.

Genentech and NVIDIA Form AI Research Collaboration for Drug Discovery and Development

November 29, 2023

Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.

MilliporeSigma Expands Biologics Testing Center in China

November 27, 2023

MilliporeSigma has expanded its biosafety testing laboratories in Shanghai, China, with the completion of new lab space at its new €29 million (US$43 million) Biologics Testing Center.

Webcasts